GPATCH4
gene geneOn this page
Also known as FLJ20249DKFZP434F1735
Summary
GPATCH4 (G-patch domain containing 4 (gene/pseudogene), HGNC:25982) is a protein-coding gene on chromosome 1q22-q23.1, encoding G patch domain-containing protein 4 (Q5T3I0).
Enables RNA binding activity. Predicted to act upstream of or within hematopoietic progenitor cell differentiation. Predicted to be active in nucleolus.
Source: NCBI Gene 54865 — automated summary from GO annotations (Alliance of Genome Resources).
At a glance
- Clinical variants (ClinVar): 68 total — 1 pathogenic
- Regional missense constraint (gnomAD): 1 of 3 regions constrained (≈5% of expected missense variation)
- GTEx eGene: eQTL in 35 tissues, sQTL in 18 (q < 0.05)
- Constraint (gnomAD): pLI 0.00 (LoF-tolerant), LOEUF 1.67 (unconstrained)
- Notable: 68 clinical variants but no curated precision-oncology (CIViC) evidence yet
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:25982 |
| Approved symbol | GPATCH4 |
| Name | G-patch domain containing 4 (gene/pseudogene) |
| Location | 1q22-q23.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ20249, DKFZP434F1735 |
| Ensembl gene | ENSG00000160818 |
| Ensembl biotype | protein_coding |
| Entrez | 54865 |
Gene structure
Transcript identifiers
Ensembl transcripts: 15 — 7 retained_intron, 3 protein_coding_LoF, 3 nonsense_mediated_decay, 2 protein_coding_CDS_not_defined
Transcript support level (Ensembl TSL; 1 = fully mRNA-supported): TSL 1: 1, TSL 2: 5, TSL 3: 5, TSL 4: 1, TSL 5: 3
ENST00000368232, ENST00000415314, ENST00000438976, ENST00000463513, ENST00000473910, ENST00000474904, ENST00000494414, ENST00000497287, ENST00000498641, ENST00000498756, ENST00000506832, ENST00000525375, ENST00000527691, ENST00000531129, ENST00000531900
RefSeq mRNA: 2
NM_015590, NM_182679
Canonical transcript exons
ENST00000368232 — 8 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001861395 | 156601409 | 156601479 |
| ENSE00001956829 | 156594301 | 156595849 |
| ENSE00003545923 | 156596081 | 156596131 |
| ENSE00003574142 | 156596387 | 156596478 |
| ENSE00003594841 | 156598968 | 156599104 |
| ENSE00003609278 | 156598227 | 156598319 |
| ENSE00003610106 | 156598035 | 156598121 |
| ENSE00003665803 | 156598421 | 156598494 |
Expression profiles
Bgee: expression breadth ubiquitous, 250 present calls, max score 95.09.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 18.9495 / max 602.8518, expressed in 1785 samples.
Highest expression (Bgee): gastrocnemius, muscle of leg, sural nerve, tibialis anterior, C1 segment of cervical spinal cord.
Genetic regulation across tissues (GTEx eQTL / sQTL)
GPATCH4 is an eGene in GTEx v10 — its expression is genetically regulated (eQTL) in 35 tissues and its splicing (sQTL) in 18 (q < 0.05). Strongest associations first; slope = normalized effect of the lead variant’s alternative allele.
showing 20 of 53 significant tissue × QTL associations:
| Tissue | QTL | q-value | Slope | Lead variant |
|---|---|---|---|---|
| Muscle Skeletal | eqtl | 3.5e-25 | -0.39 | 1:156596604:G:C |
| Brain Frontal Cortex BA9 | eqtl | 2.3e-17 | -0.68 | 1:156593649:G:A |
| Brain Cortex | eqtl | 1.6e-11 | -0.60 | 1:156583439:GC:G |
| Brain Hypothalamus | eqtl | 2.0e-11 | -0.59 | 1:156516817:C:T |
| Esophagus Muscularis | eqtl | 3.9e-10 | -0.31 | 1:156594785:A:G |
| Nerve Tibial | sqtl | 5.6e-10 | +1.05 | 1:156593649:G:A |
| Brain Putamen basal ganglia | eqtl | 6.3e-10 | -0.80 | 1:156583439:GC:G |
| Brain Nucleus accumbens basal ganglia | eqtl | 6.6e-10 | -0.56 | 1:156593649:G:A |
| Cells Cultured fibroblasts | eqtl | 3.9e-09 | +0.16 | 1:156590769:T:C |
| Muscle Skeletal | sqtl | 6.9e-09 | +0.79 | 1:156525847:C:T |
| Brain Anterior cingulate cortex BA24 | eqtl | 7.2e-09 | -0.67 | 1:156626617:C:T |
| Esophagus Mucosa | eqtl | 1.5e-07 | -0.27 | 1:156594785:A:G |
| Brain Cerebellar Hemisphere | eqtl | 2.8e-07 | -0.53 | 1:156593649:G:A |
| Cells EBV-transformed lymphocytes | sqtl | 7.8e-07 | +1.10 | 1:156593649:G:A |
| Skin Sun Exposed Lower leg | eqtl | 2.0e-06 | +0.15 | 1:156590832:C:T |
| Brain Caudate basal ganglia | eqtl | 2.7e-06 | +0.43 | 1:156625974:C:CAGG |
| Testis | eqtl | 4.2e-06 | -0.62 | 1:156594785:A:G |
| Brain Frontal Cortex BA9 | sqtl | 4.4e-06 | +1.02 | 1:156583439:GC:G |
| Artery Tibial | eqtl | 8.0e-06 | -0.29 | 1:156594785:A:G |
| Brain Cerebellum | eqtl | 2.1e-05 | -0.49 | 1:156593649:G:A |
FANTOM5 promoters
3 alternative TSS:
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 15156 | 15.5124 | 1774 |
| 15154 | 3.0961 | 1148 |
| 15155 | 0.3410 | 161 |
Top tissues by expression
showing 100 of 255 tissues by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| gastrocnemius | UBERON:0001388 | 95.09 | gold quality |
| muscle of leg | UBERON:0001383 | 94.21 | gold quality |
| sural nerve | UBERON:0015488 | 94.19 | gold quality |
| tibialis anterior | UBERON:0001385 | 93.56 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 93.36 | gold quality |
| islet of Langerhans | UBERON:0000006 | 93.07 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 92.99 | gold quality |
| prefrontal cortex | UBERON:0000451 | 92.38 | gold quality |
| right frontal lobe | UBERON:0002810 | 92.38 | gold quality |
| putamen | UBERON:0001874 | 91.82 | gold quality |
| amygdala | UBERON:0001876 | 91.80 | gold quality |
| spinal cord | UBERON:0002240 | 91.60 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 91.57 | gold quality |
| nucleus accumbens | UBERON:0001882 | 91.52 | gold quality |
| hypothalamus | UBERON:0001898 | 91.47 | gold quality |
| deltoid | UBERON:0001476 | 91.35 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 91.22 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 91.09 | gold quality |
| substantia nigra | UBERON:0002038 | 91.07 | gold quality |
| secondary oocyte | CL:0000655 | 90.94 | gold quality |
| left uterine tube | UBERON:0001303 | 90.73 | gold quality |
| neocortex | UBERON:0001950 | 90.60 | gold quality |
| frontal cortex | UBERON:0001870 | 90.48 | gold quality |
| caudate nucleus | UBERON:0001873 | 90.39 | gold quality |
| heart left ventricle | UBERON:0002084 | 90.30 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 90.20 | gold quality |
| vermiform appendix | UBERON:0001154 | 90.17 | gold quality |
| cardiac ventricle | UBERON:0002082 | 90.01 | gold quality |
| oocyte | CL:0000023 | 89.89 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 89.86 | gold quality |
| lower esophagus | UBERON:0013473 | 89.84 | gold quality |
| midbrain | UBERON:0001891 | 89.76 | gold quality |
| pancreas | UBERON:0001264 | 89.52 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 89.33 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 89.11 | gold quality |
| cerebral cortex | UBERON:0000956 | 89.08 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 88.98 | gold quality |
| cerebellar cortex | UBERON:0002129 | 88.92 | gold quality |
| esophagus | UBERON:0001043 | 88.86 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 88.85 | gold quality |
| forebrain | UBERON:0001890 | 88.81 | gold quality |
| apex of heart | UBERON:0002098 | 88.75 | gold quality |
| cortical plate | UBERON:0005343 | 88.74 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 88.65 | gold quality |
| brain | UBERON:0000955 | 88.55 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 88.54 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 88.53 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 88.50 | gold quality |
| left adrenal gland | UBERON:0001234 | 88.40 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 88.39 | gold quality |
| body of pancreas | UBERON:0001150 | 88.31 | gold quality |
| heart | UBERON:0000948 | 88.25 | gold quality |
| body of stomach | UBERON:0001161 | 88.23 | gold quality |
| caecum | UBERON:0001153 | 88.22 | gold quality |
| substantia nigra pars reticulata | UBERON:0001966 | 88.22 | gold quality |
| esophagus mucosa | UBERON:0002469 | 88.18 | gold quality |
| peritoneum | UBERON:0002358 | 88.09 | gold quality |
| omental fat pad | UBERON:0010414 | 88.08 | gold quality |
| body of uterus | UBERON:0009853 | 88.04 | gold quality |
| right atrium auricular region | UBERON:0006631 | 87.97 | gold quality |
| adrenal cortex | UBERON:0001235 | 87.95 | gold quality |
| Ammon’s horn | UBERON:0001954 | 87.94 | gold quality |
| substantia nigra pars compacta | UBERON:0001965 | 87.90 | gold quality |
| kidney epithelium | UBERON:0004819 | 87.87 | silver quality |
| right adrenal gland | UBERON:0001233 | 87.86 | gold quality |
| muscle tissue | UBERON:0002385 | 87.86 | gold quality |
| cerebellum | UBERON:0002037 | 87.83 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 87.82 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 87.74 | gold quality |
| tibial artery | UBERON:0007610 | 87.70 | gold quality |
| popliteal artery | UBERON:0002250 | 87.69 | gold quality |
| colonic epithelium | UBERON:0000397 | 87.59 | gold quality |
| tibial nerve | UBERON:0001323 | 87.51 | gold quality |
| pericardium | UBERON:0002407 | 87.50 | gold quality |
| middle temporal gyrus | UBERON:0002771 | 87.49 | gold quality |
| lymph node | UBERON:0000029 | 87.47 | gold quality |
| left coronary artery | UBERON:0001626 | 87.47 | gold quality |
| adrenal gland | UBERON:0002369 | 87.46 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 87.41 | silver quality |
| adipose tissue of abdominal region | UBERON:0007808 | 87.39 | gold quality |
| prostate gland | UBERON:0002367 | 87.28 | gold quality |
| coronary artery | UBERON:0001621 | 87.27 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 87.23 | gold quality |
| cardiac atrium | UBERON:0002081 | 87.22 | gold quality |
| temporal lobe | UBERON:0001871 | 87.10 | gold quality |
| rectum | UBERON:0001052 | 87.02 | gold quality |
| metanephros cortex | UBERON:0010533 | 87.02 | gold quality |
| stomach | UBERON:0000945 | 86.94 | gold quality |
| aorta | UBERON:0000947 | 86.78 | gold quality |
| transverse colon | UBERON:0001157 | 86.78 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 86.61 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 86.61 | gold quality |
| ectocervix | UBERON:0012249 | 86.55 | gold quality |
| quadriceps femoris | UBERON:0001377 | 86.50 | gold quality |
| right ovary | UBERON:0002118 | 86.47 | gold quality |
| left ovary | UBERON:0002119 | 86.42 | gold quality |
| colon | UBERON:0001155 | 86.39 | gold quality |
| anatomical system | UBERON:0000467 | 86.33 | gold quality |
| minor salivary gland | UBERON:0001830 | 86.32 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 86.30 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 5.92 |
| E-MTAB-7606 | no | 616.96 |
HPA expression
RNA tissue specificity: Tissue enhanced
showing 60 of 80 HPA tissues / cells by nTPM:
| Tissue / cell | Axis | nTPM | Protein (IHC) |
|---|---|---|---|
| Skeletal muscle | tissue | 30.3 | medium |
| Tongue | tissue | 26.1 | |
| Postcentral gyrus | tissue | 24.8 | |
| Caudate putamen | tissue | 20.2 | |
| Urinary bladder | tissue | 17.8 | medium |
| Frontal cortex | tissue | 17.5 | |
| Tonsil | tissue | 17.5 | low |
| Appendix | tissue | 15.5 | medium |
| Adipose tissue | tissue | 15.2 | not detected |
| Lymph node | tissue | 14.9 | not detected |
| Parathyroid gland | tissue | 14.3 | high |
| Smooth muscle | tissue | 12.9 | medium |
| Vagina | tissue | 12.8 | low |
| Liver | tissue | 12.8 | medium |
| Hippocampus | tissue | 12.6 | medium |
| Breast | tissue | 12.4 | low |
| Locus coeruleus | tissue | 12.3 | |
| Nucleus accumbens | tissue | 12.2 | |
| Rectum | tissue | 12.1 | high |
| Pancreas | tissue | 11.4 | medium |
| Adrenal gland | tissue | 11.1 | medium |
| Colon | tissue | 10.8 | medium |
| Prefrontal cortex | tissue | 10.6 | |
| Cerebral cortex | tissue | 10.6 | medium |
| Thymus | tissue | 10.4 | |
| Motor cortex | tissue | 10.3 | |
| Putamen | tissue | 10.0 | |
| Prostate | tissue | 10.0 | low |
| Esophagus | tissue | 9.9 | medium |
| Stomach 1 | tissue | 9.8 | medium |
| Seminal vesicle | tissue | 9.7 | high |
| Skin 1 | tissue | 9.6 | low |
| Salivary gland | tissue | 9.6 | not detected |
| Spleen | tissue | 9.6 | not detected |
| Kidney | tissue | 9.6 | medium |
| Bone marrow | tissue | 9.4 | low |
| Occipital cortex | tissue | 9.1 | |
| Endometrium 1 | tissue | 9.0 | low |
| Fallopian tube | tissue | 9.0 | medium |
| Somatosensory cortex | tissue | 8.9 | |
| Temporal cortex | tissue | 8.8 | |
| Placenta | tissue | 8.7 | medium |
| Thyroid gland | tissue | 8.6 | high |
| Hippocampal formation | tissue | 8.6 | |
| Entorhinal cortex | tissue | 8.6 | |
| Epididymis | tissue | 8.5 | medium |
| Basal ganglia | tissue | 8.4 | low |
| Retrosplenial and cingulate cortex | tissue | 8.4 | |
| Insular cortex | tissue | 8.4 | |
| Retrosplenial cortex | tissue | 8.3 | |
| Duodenum | tissue | 8.1 | medium |
| Ventral forebrain | tissue | 8.1 | |
| Testis | tissue | 8.0 | medium |
| Small intestine | tissue | 8.0 | medium |
| Pituitary gland | tissue | 7.8 | |
| Amygdala | tissue | 7.8 | |
| Heart muscle | tissue | 7.7 | low |
| Pons | tissue | 7.7 | |
| Septum | tissue | 7.7 | |
| Ovary | tissue | 7.5 | low |
Brain sub-regions (HPA Brain Atlas): detected in 192; highest nTPM — Somatomor cortex, precentral gyrus (white matter) (20.1), Paracentral lobule, anterior (19.8), Somatosensory cortex, postcentral gyrus, ventral (white matter) (19.3), Orbitofrontal gyrus, anterior (18.9), Median raphe nucleus (18.2).
Regulation
Is transcription factor: no
Functional genomics
gnomAD constraint: pLI 2.21e-08, LOEUF 1.67, missense Z 1.17 — population loss-of-function intolerance (pLI ≥ 0.9 = LoF-intolerant; lower LOEUF = more constrained). gnomAD
Regional missense constraint (gnomAD)
ENST00000368232 splits into 3 regions with different missense tolerance; 1 is missense-constrained (≈5% of the expected missense variation). Missense variants in a constrained region (low observed/expected) are more likely to be pathogenic. gnomAD
| Region (GRCh38) | Missense obs / exp | o/e | Constrained |
|---|---|---|---|
| 1:156,595,216–156,598,106 | 307 / 337.1 | 0.91 | no |
| 1:156,598,107–156,598,260 | 4 / 20.2 | 0.20 | yes (p 3.2e-04) |
| 1:156,598,261–156,599,046 | 68 / 85.6 | 0.79 | no |
Literature-anchored findings (GeneRIF, showing 3)
- G-patch domain-containing protein 4 localizes to both the nucleoli and Cajal bodies and regulates cell growth and nucleolar structure. (PMID:33933995)
- GPATCH4 regulates rRNA and snRNA 2’-O-methylation in both DHX15-dependent and DHX15-independent manners. (PMID:38113271)
- GPATCH4 contributes to nucleolus morphology and its dysfunction impairs cell viability. (PMID:38113722)
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | gpatch4 | ENSDARG00000091931 |
| mus_musculus | Gpatch4 | ENSMUSG00000028069 |
| rattus_norvegicus | Gpatch4 | ENSRNOG00000018969 |
| drosophila_melanogaster | CG15561 | FBGN0039829 |
Paralogs (1): PINX1 (ENSG00000254093)
Mouse-model phenotypes
Observed phenotypes of the mouse ortholog (MGI:1913864) from MGI (Alliance of Genome Resources) — knockout/mutant phenotypes, ranked by annotation count. 13 distinct phenotype terms.
| Mouse phenotype (MP) | Records |
|---|---|
| abnormal spleen morphology | 1 |
| small spleen | 1 |
| small seminal vesicle | 1 |
| decreased locomotor activity | 1 |
| abnormal seminal vesicle morphology | 1 |
| abnormal coat/hair pigmentation | 1 |
| decreased mean corpuscular volume | 1 |
| decreased lean body mass | 1 |
| immune system phenotype | 1 |
| decreased mean corpuscular hemoglobin | 1 |
| decreased CD8-positive, alpha-beta T cell number | 1 |
| increased fasting circulating glucose level | 1 |
| increased freezing behavior | 1 |
Additional cross-species homologs
Sequence homologs in species beyond Ensembl Compara’s model organisms, by Diamond local protein alignment (% sequence identity; best hit per species). Lower-identity rows are more distant homologs. The matched accessions’ gene symbols aren’t in biobtree yet, so each row shows the UniProt accession.
| Organism | UniProt | Identity | Method |
|---|---|---|---|
| Xenopus tropicalis | Q6P859 | 85.2% | Diamond |
| Xenopus laevis | Q4V842 | 84.9% | Diamond |
| Bos taurus | Q2KJE1 | 78.1% | Diamond |
Genomic neighbors (locus context)
Genes flanking this one on the chromosome (NCBI/Entrez gene neighborhood). Positional context only — some neighbors share regulatory elements (bidirectional promoters, antisense/overlapping transcripts), but chromosomal adjacency is not itself a functional relationship (see Interactions for that).
| Symbol | Type | Entrez |
|---|---|---|
| NES | protein-coding | 10763 |
| BCAN-AS2 | ncRNA | 126568844 |
| NAXE | protein-coding | 128240 |
| HAPLN2 | protein-coding | 60484 |
| BCAN | protein-coding | 63827 |
| CRABP2 | protein-coding | 1382 |
| IQGAP3 | protein-coding | 128239 |
| TTC24 | protein-coding | 164118 |
| MEF2D | protein-coding | 4209 |
Protein
Protein identifiers
G patch domain-containing protein 4 — Q5T3I0 (reviewed: Q5T3I0)
All UniProt accessions (6): A0A0A0MRK1, A0AA34QVU8, E9PAV9, E9PPY4, F2Z3C6, F8W895
UniProt curated annotations — full annotation on UniProt →
Polymorphism. This gene contains polymorphic substitutions in the last exon causing a frameshift variant C-terminal sequence compared to the official human genome. However, this variant sequence is in agreement with ortholog sequences.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q5T3I0-1 | 1 | yes |
| Q5T3I0-2 | 2 | |
| Q5T3I0-3 | 3 |
RefSeq proteins (2): NP_056405, NP_872620 (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000467 | G_patch_dom | Domain |
| IPR050656 | PINX1 | Family |
Pfam: PF01585
UniProt features (24 total): compositionally biased region 8, modified residue 6, splice variant 4, region of interest 2, chain 1, domain 1, cross-link 1, coiled-coil region 1
Structure
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q5T3I0-F1 | 57.52 | 0.12 |
Human Protein Atlas
Protein class: Predicted intracellular proteins
Protein evidence: Evidence at protein level
Subcellular location (HPA, imaging): nucleoli; nucleoplasm
Antibody reliability (HPA): IH approved · IF enhanced
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (7)
| Type | Positions |
|---|---|
| N-acetylmethionine | 1 |
| Phosphothreonine | 4, 116 |
| Phosphoserine | 128, 130, 139 |
| Glycyl lysine isopeptide (lys-gly) (interchain with g-cter in sumo2) | 46 |
Function
Pathways and Gene Ontology
Reactome pathways
0 curated (TAS) of 0; 0 disease pathways. Curated-first; evidence = TAS (manually curated) vs IEA (electronic inference).
MSigDB gene sets: 151 (showing top):
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1, WANG_LMO4_TARGETS_DN, MILI_PSEUDOPODIA_HAPTOTAXIS_UP, YY1_02, GARY_CD5_TARGETS_DN, FISCHER_DREAM_TARGETS, IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR, NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP, NUYTTEN_EZH2_TARGETS_DN, GOCC_NUCLEOLUS, STAT5A_01, MATSUDA_NATURAL_KILLER_DIFFERENTIATION, ATGAAGG_MIR205, KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN, KOYAMA_SEMA3B_TARGETS_DN
GO Molecular Function (2): RNA binding (GO:0003723), nucleic acid binding (GO:0003676)
GO Cellular Component (1): nucleolus (GO:0005730)
GO top-level categories
4 GO namespaces:
| Category | Terms |
|---|---|
| nucleic acid binding | 1 |
| binding | 1 |
| nuclear lumen | 1 |
| intracellular membraneless organelle | 1 |
Experimentally-supported GO annotations
GO terms backed by direct experimental evidence (ECO experimental codes) — 1 of 3 annotations. The rest are phylogenetic / computational / electronic (IEA).
1 experimentally-supported GO terms:
| GO term | NS | Evidence |
|---|---|---|
| RNA binding | MF | high-throughput assay |
Protein interactions and networks
STRING
showing 15 of 1,388 interactions by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| GPATCH4 | TMEM52 | Q8NDY8 | 567 |
| GPATCH4 | SINHCAF | Q9NP50 | 453 |
| GPATCH4 | RP1L1 | Q8IWN7 | 438 |
| GPATCH4 | NXPH4 | O95158 | 424 |
| GPATCH4 | MYBBP1A | Q9BQG0 | 413 |
| GPATCH4 | RPL36 | Q9Y3U8 | 410 |
| GPATCH4 | TBCB | Q99426 | 399 |
| GPATCH4 | SAXO5 | Q8NA69 | 395 |
| GPATCH4 | CFAP45 | Q9UL16 | 387 |
| GPATCH4 | MAGIX | Q9H6Y5 | 384 |
| GPATCH4 | NUFIP2 | Q7Z417 | 378 |
| GPATCH4 | ZNF250 | P15622 | 378 |
| GPATCH4 | PEAR1 | Q5VY43 | 370 |
| GPATCH4 | STEAP2 | Q8NFT2 | 362 |
| GPATCH4 | PELI2 | Q9HAT8 | 357 |
IntAct
Human interaction partners of GPATCH4 in IntAct, one row per partner (best MIscore; records = supporting IntAct interaction records).
2 partners by confidence:
| Partner | Interaction type | MIscore | Records |
|---|---|---|---|
| CEP70 | physical association | 0.720 | 6 |
| KASH5 | physical association | 0.720 | 6 |
Disease & clinical
Genetic variants
Variant evidence for GPATCH4: 68 ClinVar records (1 pathogenic / likely pathogenic). Per-variant detail is on Sugi Variant.
ClinVar
68 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 0 |
| Uncertain significance | 54 |
| Likely benign | 3 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (1)
Showing all 1 pathogenic / likely-pathogenic ClinVar records, ranked by ClinVar review status (expert panel → multiple submitters → single submitter), then by number of submitting labs.
| Variant ID | HGVS | Classification | Review | Submitters |
|---|---|---|---|---|
| 2427315 | NC_000001.10:g.(?156554669)(156568838_?)del | Pathogenic | criteria provided, single submitter | 1 |
Per-variant reference — Sugi Variant
Explore GPATCH4’s pathogenic and likely-pathogenic variants individually — each with its ClinVar classification and conditions, applied ACMG criteria (ClinGen expert panel, where curated), the calibrated in-silico predictors (AlphaMissense, REVEL, SaProt, conservation), gnomAD frequency, and the predictor-disagreement QC signal — on Sugi Variant.
SpliceAI
Top 10 splice-impact sites by Δscore (adjacent positions with the same effect merged into one range; 36 predictions of 663):
| Position(s) | Effect | Δscore | Sites |
|---|---|---|---|
| 1:156598225–156598226 | donor_loss | 1.0000 | 5 |
| 1:156598320–156598321 | acceptor_loss | 1.0000 | 6 |
| 1:156598324 | acceptor_gain | 1.0000 | |
| 1:156601407–156601408 | donor_loss | 1.0000 | 4 |
| 1:156595850–156595851 | acceptor_loss | 0.9900 | 6 |
| 1:156596388 | donor_gain | 0.9900 | |
| 1:156598122–156598123 | acceptor_loss | 0.9900 | 5 |
| 1:156598229 | donor_gain | 0.9900 | |
| 1:156598325 | acceptor_gain | 0.9900 | |
| 1:156598419–156598420 | donor_loss | 0.9900 | 6 |
HPA cancer prognostics
RNA cancer specificity: Low cancer specificity
Human Protein Atlas survival analysis — favorable = higher expression predicts better survival.
2 prognostic cancer types:
| Cancer | Prognostic | p-value |
|---|---|---|
| Kidney Chromophobe (TCGA) | unfavorable | 2.39e-05 |
| Liver Hepatocellular Carcinoma (TCGA) | unfavorable | 3.73e-05 |
Disease associations
OMIM: gene `` | disease phenotypes:
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (CPIC guideline: no)
CTD chemical–gene interactions
49 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | increases expression, affects expression, decreases expression, increases methylation, affects cotreatment | 6 |
| trichostatin A | affects cotreatment, increases expression | 3 |
| sodium arsenite | decreases expression, affects cotreatment, increases abundance, increases expression | 3 |
| Estradiol | affects expression, increases expression | 3 |
| (+)-JQ1 compound | affects expression, decreases expression | 2 |
| Arsenic | affects cotreatment, increases abundance, increases expression | 2 |
| Nickel | increases expression | 2 |
| Tretinoin | decreases expression | 2 |
| GSK-J4 | decreases expression | 1 |
| afuresertib | decreases expression | 1 |
| FR900359 | affects phosphorylation | 1 |
| TAK-243 | increases sumoylation | 1 |
| TL8-506 | affects cotreatment, increases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| bisphenol A | decreases expression | 1 |
| beta-lapachone | increases expression | 1 |
| arsenite | increases methylation | 1 |
| manganese chloride | increases expression, affects cotreatment, increases abundance | 1 |
| potassium chromate(VI) | affects cotreatment, increases expression | 1 |
| coumarin | affects phosphorylation | 1 |
| epigallocatechin gallate | affects cotreatment, increases expression | 1 |
| cylindrospermopsin | increases expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, increases expression | 1 |
| abrine | increases expression | 1 |
| dorsomorphin | affects cotreatment, increases expression | 1 |
| 3-(2-hydroxy-4-(2-methylnonan-2-yl)phenyl)cyclohexan-1-ol | decreases expression | 1 |
| Irinotecan | decreases expression | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Acetaminophen | decreases expression | 1 |
| Atrazine | decreases expression | 1 |
Cellosaurus cell lines
1 cell lines: 1 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_B2Y3 | Abcam HEK293T GPATCH4 KO | Transformed cell line | Female |
Clinical trials (associated diseases)
Via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.